Very Rare Cancer Consortium Disease Spotlight & Research Roundtable

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions.

HEPATOBLASTOMA
Disease Spotlight & Research Roundtable

Please note registration is required.

Hepatoblastoma is the most common liver neoplasm in children and accounts for 1% of all childhood malignancies. Over the last decade, the incidence of Hepatoblastoma has nearly doubled, faster than any other childhood cancer, however in this time we have gained little ground in understanding the molecular characteristics that drive the disease. The five-year survival for Hepatoblastoma is estimated at 60-70%, one of the lowest survival rates for childhood cancer, demanding translational studies to improve our understanding of the disease and enable the development of targeted and more effective clinical therapies.

During this VRCC Roundtable focused on Hepatoblastoma, we will hear from a panel of experts and discuss our current understanding of the disease, advances being made in treatment and research, studies needed to improve patient care, and how we might be able to work together to move to field forward.

Any questions on this event, contact events@nygenome.org.

Speakers

• 

  Robert E. Schwartz, MD, PhD

  Assistant Professor of Medicine
  Division of Gastroenterology and Hepatology
  Weill Cornell Medicine

• 

  Allison O'Neill, MD

  Clinical Director, Solid Tumor Center
  Director of Medical Therapies, Liver Tumor CenterSenior Physician
  Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
  Assistant Professor of Pediatrics
  Harvard Medical School

• 

  Dolores López-Terrada, MD, PhD

  Professor of Pathology and Pediatrics
  Baylor College of Medicine
  Division Chief, Genomic Medicine
  Texas Children’s Hospital Department of Pathology

• Logan G. Spector, PhD

  Suzanne Holmes Hodder Chair in Pediatric Cancer
  Research Director, Division of Epidemiology/Clinical Research
  Department of Pediatrics
  University of Minnesota

• 

  Eiso Hiyama, MD, PhD

  Professor, Department of Pediatric Surgery
  Hiroshima University Hospital
  Director, Natural Science Center for Basic Research and Development (N-BARD)
  Hiroshima University

• 

  Shauna L. Houlihan, PhD

  Associate Director of Liver Research
  Englander Institute for Precision Medicine
  Weill Cornell Medicine
  Scientific Director, Very Rare Cancer Consortium
  New York Genome Center

• 

  James I. Geller, MD

  Director – Liver, Kidney and Retinoblastoma Programs, Cancer and Blood Diseases Institute
  Director, Advanced Cancer Therapy Network, Cancer and Blood Disease Institute
  Director, Pilot Translational Core Grant Program, Center for Clinical and Translational Science and Training
  Professor, UC Department of Pediatrics
  Cincinnati Children’s Hospital Medical Center